Kaname Nakatani Selected Research

Kaname Nakatani Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 04/2002
14	Insulin Resistance 10/2006 - 06/2002
9	Type 2 Diabetes Mellitus (MODY) 07/2013 - 06/2002
6	Disseminated Intravascular Coagulation 07/2018 - 07/2002
6	Thrombosis (Thrombus) 09/2015 - 07/2003
5	Venous Thromboembolism 01/2018 - 04/2008
4	Infections 01/2021 - 07/2002
4	Thrombophilia 10/2018 - 02/2003
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 10/2020
3	Venous Thrombosis (Deep-Vein Thrombosis) 05/2018 - 04/2008
3	Obesity 09/2005 - 10/2003
3	Hyperinsulinism (Hyperinsulinemia) 11/2004 - 07/2002
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 04/2022 - 07/2021
2	Microsatellite Instability 03/2021 - 01/2021
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2017 - 03/2012
2	Bronchiectasis 06/2016 - 07/2010
2	Pulmonary Embolism 06/2010 - 04/2008
1	Cystic Fibrosis (Mucoviscidosis) 05/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Frailty 01/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2021
1	Sarcopenia 01/2021
1	Hypokalemia 11/2020
1	Hypoalbuminemia 11/2020
1	Acute Kidney Injury (Acute Renal Failure) 11/2020
1	Infarction (Infarctions) 01/2019
1	Macular Edema 01/2019
1	Hemophilia A (Haemophilia) 07/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Protein C Deficiency 01/2017
1	Spontaneous Abortion (Miscarriage) 01/2017
1	hereditary Thrombophilia 01/2017
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2016
1	Circulating Neoplastic Cells 05/2016
1	Methylenetetrahydrofolate reductase deficiency 01/2014
1	Leukoencephalopathies 01/2014
1	Drug-Related Side Effects and Adverse Reactions 11/2013
1	Albuminuria 07/2013

Drug/Important Bio-Agent (IBA)

10	Glucose (Dextrose)FDA LinkGeneric 10/2006 - 07/2002
6	Proteins (Proteins, Gene)FDA Link 07/2021 - 10/2004
6	Protein SIBA 10/2018 - 06/2010
6	AntithrombinsIBA 10/2018 - 07/2002
6	Dacarbazine (DIC)FDA LinkGeneric 07/2018 - 07/2002
5	FibrinIBA 07/2018 - 07/2003
5	fibrin fragment D (D-dimer)IBA 05/2018 - 02/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2005
4	Protein CIBA 10/2018 - 01/2005
4	AdiponectinIBA 10/2006 - 10/2003
4	Triglycerides (Triacylglycerol)IBA 09/2005 - 08/2003
4	Insulin (Novolin)FDA Link 03/2005 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2021
3	Fibrinogen (Factor I)FDA Link 01/2017 - 11/2008
3	Messenger RNA (mRNA)IBA 05/2011 - 06/2004
3	EnzymesIBA 04/2005 - 04/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2022 - 07/2010
2	Immune Checkpoint InhibitorsIBA 03/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 04/2005
2	Cytochrome P-450 CYP3AIBA 01/2018 - 01/2013
2	Adenosine Triphosphate (ATP)IBA 01/2018 - 01/2013
2	Pharmaceutical PreparationsIBA 05/2016 - 11/2013
2	Hemostatics (Antihemorrhagics)IBA 09/2015 - 07/2003
2	protein S TokushimaIBA 01/2012 - 09/2010
2	GhrelinIBA 09/2005 - 11/2004
2	Thrombin FDA Link 01/2005 - 07/2002
2	AdrenomedullinIBA 05/2003 - 07/2002
1	rho-Associated KinasesIBA 05/2022
1	C-Reactive ProteinIBA 12/2021
1	imidazoleacetic acid (IMAC)IBA 01/2021
1	Serum AlbuminIBA 01/2021
1	pembrolizumabIBA 01/2021
1	mitomycin C-immunoglobulin M antibody conjugateIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	AntibodiesIBA 07/2018
1	Factor VIII (Coagulation Factor VIII)IBA 07/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2018
1	edoxabanIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 10/2016
1	Amino Acids FDA Link 10/2016
1	AntigensIBA 09/2015
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014
1	CreatinineIBA 07/2013
1	Angiotensin Receptor AntagonistsIBA 07/2013
1	benazepril (Briem)FDA LinkGeneric 07/2013
1	azelnidipineIBA 07/2013
1	olmesartanIBA 07/2013
1	Amlodipine (Norvasc)FDA LinkGeneric 07/2013
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 07/2013

Therapy/Procedure

6	Therapeutics 01/2021 - 06/2002
3	Drug Therapy (Chemotherapy) 01/2017 - 01/2006
2	Orthopedic Procedures 01/2018 - 01/2017
2	Aftercare (After-Treatment) 04/2008 - 06/2002
1	Intravitreal Injections 01/2019
1	Radiotherapy 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017